Asset Optimization & Commercialization

Photo of bridge at night with light trails from cars on it with city in the distance

There is no “one size fits all” approach to creating the right development and commercial strategy for your platform and asset. Defining the opportunity, differentiating your platform and asset, and demonstrating value beyond standard of care is vital and has become more challenging in an increasingly complex and competitive context. Lumanity does more than guide your development and commercial strategy; we uncover real world insights that go beyond the ‘what’ to understand the ‘why’, providing pharmaceutical and biotech companies with robust strategies they can be confident in across the lifecycle: from innovation through development to commercialization and beyond.

We Can Help You:

Our Impact

25+
With extensive experience across multiple therapy areas and geographies, we’ve been developing, co-creating, and pressure testing brand and pharmaceutical launch strategies across the lifecycle for 25+ years
30
We support an average of 30 brand launches per year, including a large concentration of those in rare disease, advanced therapeutics, immuno-oncology, and cardiology
60+
We work with a network of partners across 60 markets around the world

Our Work

Let's Talk

We would love to hear your challenge and discuss how our team of market insight and commercialization strategy experts can help.

Jane Shirley, Global Practice Lead, Asset Optimization & Commercialization at Lumanity
Jane Shirley Global Practice Lead, Asset Optimization & Commercialization
Read more about Jane Shirley
Tom Atkinson Group Business Director, Insight
Read more about Tom Atkinson
Jane Ayton Senior Vice President, Commercial Consulting
Read more about Jane Ayton
Jeffrey Bockman, Executive Vice President, Head of Oncology Practice at Lumanity
Jeffrey M. Bockman Executive Vice President, BioConsulting and Head of Oncology
Read more about Jeffrey M. Bockman
Nicola Cowland Global President, Insight
Read more about Nicola Cowland
Janet Czachura Principal Consultant and Director of Knowledge Management, BioConsulting
Read more about Janet Czachura
Gerard Doherty Vice President, Commercial Consulting
Read more about Gerard Doherty
Damian Eade, Managing Director, Asset Optimization & Commercialization
Damian Eade Managing Director, Social Analytics, Insight
Read more about Damian Eade
Marie-Therese Eade Client Strategy Director, Insight
Read more about Marie-Therese Eade
Alex Fink Senior Vice President - Europe, Commercial Consulting
Read more about Alex Fink
Yuliya Fontanetti Global Director, Project Manager and Compliance, Insight
Read more about Yuliya Fontanetti
Beth Fordham-Meier, VP, Business Development & Head, Corporate & Partnering Strategy Practice at Lumanity
Beth Fordham-Meier Vice President, Business Development, BioConsulting, Head of Corporate & Partnering Strategy
Read more about Beth Fordham-Meier
Ken Garfinkel, Forecasting Director at Lumanity
Ken Garfinkel Forecasting Director, Commercial Consulting
Read more about Ken Garfinkel
Ed Geiselhart, Director at Lumanity
Ed Geiselhart Head of Experience First, Insight
Read more about Ed Geiselhart
Leslie Goldberg, Managing Director at Lumanity
Leslie Goldberg Managing Director, Commercial Consulting
Read more about Leslie Goldberg
Juan Hernández Head of Advanced Analytics, Insight
Read more about Juan Hernández
Ginger S. Johnson, President, US Consulting at Lumanity
Ginger S. Johnson President, BioConsulting, Central Nervous System Co-Lead
Read more about Ginger S. Johnson
Roz Lawson Vice President, Commercial Consulting
Read more about Roz Lawson
David Lomb Vice President, Director of Consulting Services, BioConsulting, Autoimmune and Inflammatory Disease Co-Lead
Read more about David Lomb
Danielle Marra, Principal at Lumanity
Danielle Marra Principal, Autoimmune and Inflammatory Disease Co-Lead, BioConsulting
Read more about Danielle Marra
Steve Mather Global President, Commercial Consulting
Read more about Steve Mather
Duncan Munro, Head of IQ at Lumanity
Duncan Munro Head of Quantitative, Insight
Read more about Duncan Munro
Gareth Nicol, Group Business Director at Lumanity
Gareth Nicol Group Business Director, Insight
Read more about Gareth Nicol
Michael C Rice Senior Vice President, BioConsulting, Head of Advanced Therapeutics and Rare Diseases
Read more about Michael C Rice
Laura Sarokin Senior Vice President, Commercial Consulting
Read more about Laura Sarokin
Edward C. Saltzman Head, Biotech Strategy
Read more about Edward C. Saltzman
Joel Sandler, Principal, Head of Cancer Cell Therapy Practice at Lumanity
Joel Sandler Principal, BioConsulting, Cancer Cell Therapy Lead, Central Nervous System Co-Lead
Read more about Joel Sandler
Peter Smith Senior Vice President, Commercial Consulting
Read more about Peter Smith
Heike Tombrink Head of Germany, Insight
Read more about Heike Tombrink
Gracie van Kemenade, Group Director, Head of IQ Practice at Lumanity
Gracie van Kemenade Head of Quantitative, Insight
Read more about Gracie van Kemenade
Angela Wheeler
Angela Wheeler President, Insight US
Read more about Angela Wheeler
AndrewWood
Andrew Wood Head of Behavioral Science, Insight
Read more about Andrew Wood